Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin–Tazobactam and Amoxicillin–Clavulanate for the Treatment of Complicated Intra-abdominal Infections

OBJECTIVE: To compare the safety and efficacy of sequential intravenous (IV) to oral (PO) moxifloxacin treatment against a standard antimicrobial regimen of IV piperacillin–tazobactam followed by PO amoxicillin–clavulanate for the treatment of adults with complicated intra-abdominal infection (cIAI)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Malangoni, Mark A., Song, James, Herrington, Janet, Choudhri, Shurjeel, Pertel, Peter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2006
Gaiak:
Randomized, Controlled Trials
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1602153/
https://ncbi.nlm.nih.gov/pubmed/16858182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.sla.0000230024.84190.a8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak